Our mission is to set the standard of cancer care, not just follow it. I do this through cutting edge translational research with radiation in areas that attack at the heart of cancer including DNA repair and immunology. Most important is the offering of compassionate and competent care of my patients from diagnosis through the journey of cancer care with the goal of growing old together.

My passion is to care for the patient with cancer using every ounce of expertise and compassion inside me.

Locations

Monday: 9am - 5pm
Tuesday: 9am - 5pm
Wednesday: 9am - 5pm
Thursday: 9am - 5pm
Friday: 9am - 5pm
Saturday: Closed
Sunday: Closed
Monday: 8am - 4pm
Tuesday: 8am - 4pm
Wednesday: 8am - 4pm
Thursday: 8am - 4pm
Friday: 8am - 4pm
Saturday: Closed
Sunday: Closed
Monday: 8am - 5pm
Tuesday: 8am - 5pm
Wednesday: 8am - 5pm
Thursday: 8am - 5pm
Friday: 8am - 5pm
Saturday: Closed
Sunday: Closed
Monday: 8am - 5pm
Tuesday: 8am - 5pm
Wednesday: 8am - 5pm
Thursday: 8am - 5pm
Friday: 8am - 5pm
Saturday: Closed
Sunday: Closed

Qualifications and experience

Specialties
Radiation Oncology, Cancers, Ear, Nose, and Throat (ENT), Ear, Nose, and Throat (ENT) - Head and Neck Tumors, Cancers - Prostate Cancer, Cancers - Lung Cancer, Radiology, Cancers - Radiation Therapy, Cancers - Head and Neck Cancer
Gender
Male
Languages spoken
English
Education
Medical School
Wake Forest University School of Medicine (1990)

Residency
Johns Hopkins University School of Medicine Program (1994)

Clinical interest for patients

Dr. Raben has developed nationally recognized clinical expertise over the past 20 years in the management of head and neck cancer (HNC), lung cancer and prostate/bladder cancers. He was the first to introduce intensity modulated radiation techniques for HNC and the first to spare the critical salivary glands and thyroid glands for patients undergoing radiation. For prostate cancer Dr. Raben first introduced accelerated hypofractionated radiation to the prostate while simultaneously treating the lymph nodes in the Rocky Mountain region, shortening overall treatment time to 5.5 weeks from 8.5 weeks with no increase in long term side effects and excellent outcomes. Dr. Raben has extensive experience spanning over 20 years with low (LDR) and high dose rate (HDR) brachytherapy for prostate cancer.

Volunteer activities

Denver Bridge Project
Health Volunteers Overseas

Region
Metro Denver